生命科学资讯

CTAD 2025: The challenges of combination therapies for dementia

AR degradation inducers disclosed in Qingdao Putaike Biomedical patent

Genescience discovers new salts of MC4 receptor antagonists

Appointments and advancements for Dec. 3, 2025

Financings for Dec. 3, 2025

In the clinic for Dec. 3, 2025

Other news to note for Dec. 3, 2025

Regulatory actions for Dec. 3, 2025

Chinese scientists divulge new XOR inhibitors

Zhimeng Biopharma describes new compounds to treat HBV infection

New TP53 stabilizers disclosed in Shanghai Qilu Pharmaceutical patent

Shenzhen Forward Pharmaceuticals discovers new FGFR2 inhibitors

In the clinic for Dec. 2, 2025

Other news to note for Dec. 2, 2025

Regulatory actions for Dec. 2, 2025

US pediatric voucher making moves in Congress

More uncertainty at FDA as Pazdur plans to resign

Hightide’s HTD-1801 outperforms Farxiga in type 2 diabetes

Subcutaneous biologics maker Bao Pharma prices $128M IPO

News in brief